5 Best Healthcare Stocks to Buy Under $20

Page 5 of 5

1. Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Number of Hedge Fund Holders: 50

Share Price: $13.3

On February 12, Piper Sandler analysts placed an Overweight rating and $19 price target on Teva Pharmaceutical Industries Limited (NYSE:TEVA).

Teva Pharmaceutical Industries Limited (NYSE:TEVA) had 50 hedge funds long its stock in the fourth quarter, with a total stake value of $1.5 billion.

Based in Tel Aviv, Israel, Teva Pharmaceutical Industries Limited (NYSE:TEVA) is a pharmaceutical company. It offers generic medicines, specialty medicines, and biopharmaceutical products.

Sound Shore Management mentioned Teva Pharmaceutical Industries Limited (NYSE:TEVA) in its third-quarter 2023 investor letter:

“Away from power, drug maker Teva Pharmaceutical Industries Limited (NYSE:TEVA), a new holding, also performed well during the quarter. Teva develops, manufactures and markets generic and specialty drugs focused on neurological and respiratory diseases, as well as oncology. Following a period of poor capital allocation decisions in prior years, we were able to invest at a very attractive valuation. We now believe management has positioned the company for renewed growth, driven by its most promising branded drug pipeline in years. The investment is off to a good start and the stock gained after second quarter results topped consensus.”

Follow Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

See also Insiders Are Dumping These 10 Healthcare Stocks and 11 Best Healthcare ETFs To Buy Now.

Page 5 of 5